Nasdaq Biotechnology Ishares (IBB) 304.46 $IBB
Biotech Stocks Slump Again on Valeant's 'Smoking Gun'
at The Street - Wed Oct 21, 3:02PM CDT
Biotech stocks were in the crossfire again on Wednesday as investors fled. But this time Hillary Clinton wasn't to blame.
KO: 42.19 (-0.10), VRX: 118.61 (-28.13), F: 15.41 (+0.03), KMB: 118.09 (+0.87), PFE: 33.46 (-0.54), IBB: 304.46 (-1.50), FCAU: 15.20 (-0.74), LLY: 77.01 (-0.78), TM: 123.70 (+1.49), BMY: 62.51 (-1.38), BA: 141.19 (+2.31), GM: 35.42 (+1.94), ABBV: 53.83 (-1.00), HMC: 32.70 (+0.70), RACE: 55.00 (-5.00)
Stocks Fall; Valeant Defends Accounting Practices
at The Street - Wed Oct 21, 2:02PM CDT
Stocks relinquish gains made earlier Wednesday as a selloff in Valeant Pharmaceuticals pressures the rest of the biotech sector.
TSLA: 210.09 (-2.94), BIIB: 276.34 (+10.53), F: 15.41 (+0.03), VRX: 118.61 (-28.13), KMB: 118.09 (+0.87), IBB: 304.46 (-1.50), TM: 123.70 (+1.49), SBUX: 60.53 (-0.35), YHOO: 31.12 (-1.71), CMG: 665.67 (-39.96), ABBV: 53.83 (-1.00), GOOGL: 671.80 (-8.20), HMC: 32.70 (+0.70), AAPL: 113.76 (-0.01), KO: 42.19 (-0.10), AMZN: 555.77 (-5.11), MU: 16.43 (-0.66), PFE: 33.46 (-0.54), LLY: 77.01 (-0.78), FCAU: 15.20 (-0.74), BMY: 62.51 (-1.38), BA: 141.19 (+2.31), WDC: 71.44 (-3.42), LRCX: 70.79 (+0.76), MCD: 102.54 (-1.30), GM: 35.42 (+1.94), KLAC: 63.98 (+10.12), RACE: 55.00 (-5.00), SNDK: 76.78 (+1.59)
Carl Icahn Forming Super PAC to Push Corporate Tax Reform
at The Street - Wed Oct 21, 1:26PM CDT
The CNBC 'Fast Money' traders get the latest on the Valeant Pharma stock plunge, then hear from Carl Icahn on why he's forming a super PAC focused on corporate taxes.
VRX: 118.61 (-28.13), SPY: 201.85 (-1.24), GM: 35.42 (+1.94), IBB: 304.46 (-1.50), BA: 141.19 (+2.31), AAPL: 113.76 (-0.01)
Stocks Turn Lower as Valeant Dents Biotech Sector
at The Street - Wed Oct 21, 9:41AM CDT
Stocks turn lower by mid-morning Wednesday as plummeting Valeant Pharmaceuticals shares pull the biotech sector to the downside.
BIIB: 276.34 (+10.53), TSLA: 210.09 (-2.94), VRX: 118.61 (-28.13), KMB: 118.09 (+0.87), IBB: 304.46 (-1.50), SBUX: 60.53 (-0.35), YHOO: 31.12 (-1.71), CMG: 665.67 (-39.96), ABBV: 53.83 (-1.00), GOOGL: 671.80 (-8.20), AAPL: 113.76 (-0.01), KO: 42.19 (-0.10), AMZN: 555.77 (-5.11), MU: 16.43 (-0.66), PFE: 33.46 (-0.54), FCAU: 15.20 (-0.74), BA: 141.19 (+2.31), WDC: 71.44 (-3.42), CELG: 115.92 (-0.32), GILD: 101.73 (+0.07), LRCX: 70.79 (+0.76), GM: 35.42 (+1.94), MCD: 102.54 (-1.30), KLAC: 63.98 (+10.12), RACE: 55.00 (-5.00), SNDK: 76.78 (+1.59)
Stocks Slide as Health Care Selloff Dings Nasdaq
at The Street - Tue Oct 20, 1:37PM CDT
Stocks are lower by mid-afternoon Tuesday, pulled down by weakness in the tech and health care sectors.
BIIB: 276.34 (+10.53), TSLA: 210.09 (-2.94), GE: 28.85 (+0.07), VRX: 118.61 (-28.13), HOG: 47.03 (-1.22), UTX: 97.97 (+2.35), TFM: 26.64 (-0.96), IBB: 304.46 (-1.50), T: 33.60 (-0.15), SONC: 27.87 (-0.82), IBM: 140.92 (+0.28), S: 4.34 (-0.02), XLK: 41.70 (-0.32), SYF: 32.46 (+0.12), GOOGL: 671.80 (-8.20), TMUS: 40.22 (-0.48), YUM: 73.56 (+0.53), TRV: 110.70 (+1.75), AMSG: 71.56 (-3.32), AMZN: 555.77 (-5.11), PFE: 33.46 (-0.54), WDC: 71.44 (-3.42), VOD: 31.93 (-0.27), UAL: 54.55 (-1.20), NFLX: 97.96 (-1.03), LVLT: 47.36 (-0.73), GILD: 101.73 (+0.07), WTW: 15.40 (-2.85), TMH: 61.77 (-0.82), VZ: 44.86 (-0.38), SNDK: 76.78 (+1.59), BABA: 69.48 (-2.31)
Breakthrough Biotech ETF on Cancer Treatment
Zacks Equity Research - Zacks Investment Research - Mon Oct 19, 12:54PM CDT
Want exposure to an innovative biotech field? The first cancer immunotherapy ETF (CNCR) is now within your reach.
BBP: 28.82 (+0.02), BBC: 26.84 (-0.09), SBIO: 28.07 (-0.21), CNCR: 26.22 (-0.24), IBB: 304.46 (-1.50), XLV: 68.29 (-0.62)
Bull of the Day: Repligen (RGEN)
Kevin Cook - Zacks Investment Research - Mon Oct 19, 8:01AM CDT
Bull of the Day: Repligen (RGEN)
RGEN: 30.65 (-0.06), GE: 28.85 (+0.07), TMO: 127.11 (-1.51), IBB: 304.46 (-1.50)
The Best Way to Invest $1,000 Right Now
Sean Williams, Selena Maranjian, and Dan Caplinger, The Motley Fool - Motley Fool - Sun Oct 18, 10:11AM CDT
Image source: Federal Reserve Bank of New York. They say you need money to make money, but everyone needs to start somewhere. So why not now? With this in mind, we posed the following question to three of our investment planning contributors:...
IBB: 304.46 (-1.50)
3 Biotechs Stocks That We Think The Market Has All Wrong
Brian Feroldi, Todd Campbell, and George Budwell, The Motley Fool - Motley Fool - Sat Oct 17, 12:41PM CDT
Image Source: TBIT via pixabay It's been a rough couple of months for biotech investors, as the entire sector has been sold off hard since the summer. The iShares Nasdaq Biotechnology ETF , which holds a huge collection of biotech stocks, is down...
INSY: 23.66 (-0.70), GWPH: 85.62 (-3.60), IBB: 304.46 (-1.50), DEPO: 16.12 (-0.95)
Is the Recent Stock Rally About to End?
at The Street - Fri Oct 16, 1:58PM CDT
A majority of the CNBC 'Fast Money' traders aren't buying into the recent stock rally that has sent the S&P 500 higher by 5.5% this month.
SPY: 201.85 (-1.24), GILD: 101.73 (+0.07), IBB: 304.46 (-1.50), MSFT: 47.20 (-0.57), TWTR: 29.30 (-1.61)
iShares Nasdaq Biotechnology Index Set to Possibly Pullback After Yesterday's Rally of 4.37%
Comtex SmarTrend(R) - Thu Oct 15, 3:46PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $297.38 to a high of $314.85. Yesterday, the shares gained 4.4%, which took the trading range above the 3-day high of $312.48 on volume of 3.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 304.46 (-1.50)
SmarTrend Watching for Potential Pullback in Shares of iShares Nasdaq Biotechnology Index After 4.37% Gain
Comtex SmarTrend(R) - Thu Oct 15, 3:46PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $297.38 to a high of $314.85. Yesterday, the shares gained 4.4%, which took the trading range above the 3-day high of $312.48 on volume of 3.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 304.46 (-1.50)
These 3 Biotechs Have Been Falling Like a Knife in 2015 -- Is 1 Now a Buy?
George Budwell, The Motley Fool - Motley Fool - Thu Oct 15, 8:37AM CDT
Source: Pixabay. After a long bull run, biotech has finally stubbed its proverbial toe in 2015, with the iShares Nasdaq Biotechnology Index giving back nearly all of its gains from earlier in the year: Worse still, numerous biotechs...
OVAS: 14.41 (+0.38), IBB: 304.46 (-1.50), KERX: 4.62 (+0.02)
Downtrend Call Working As iShares Nasdaq Biotechnology Index Stock Falls 6.9% (IBB)
Comtex SmarTrend(R) - Wed Oct 14, 10:12AM CDT
SmarTrend identified a Downtrend for iShares Nasdaq Biotechnology Index (AMEX:IBB) on September 24th, 2015 at $326.22. In approximately 3 weeks, iShares Nasdaq Biotechnology Index has returned 6.87% as of today's recent price of $303.81.
IBB: 304.46 (-1.50)
Trader's Notebook: Post-Debate Biotech and Post-Earnings Bank of America
at The Street - Wed Oct 14, 8:00AM CDT
How to play the IBB and earnings from Intel, BAC, Delta and Netflix.
NFLX: 97.96 (-1.03), DAL: 49.44 (-0.71), IBB: 304.46 (-1.50), BAC: 15.90 (-0.30), INTC: 33.37 (-0.07)
Five Biotech Stocks, Including Biogen (BIIB), With Bullish Charts, Pushing the Sector Higher
at The Street - Tue Oct 13, 3:00PM CDT
The common thread in these five names is the bullish divergence between the lower lows in price and the higher low in the momentum study.
BIIB: 276.34 (+10.53), GILD: 101.73 (+0.07), AMGN: 150.09 (-0.36), IBB: 304.46 (-1.50), REGN: 518.53 (+3.86), CELG: 115.92 (-0.32)
5 Biotech Stocks With Bullish Charts That Will Push the Sector Higher
at The Street - Tue Oct 13, 2:30PM CDT
The common thread in these 5 names is the bullish divergence between the lower lows in price and the higher low in the momentum study.
BIIB: 276.34 (+10.53), GILD: 101.73 (+0.07), AMGN: 150.09 (-0.36), IBB: 304.46 (-1.50), REGN: 518.53 (+3.86), CELG: 115.92 (-0.32)
Trader's Notebook: Johnson & Johnson May Be Worth a Look
at The Street - Tue Oct 13, 8:00AM CDT
And watch out for surprises in the biotech sector.
BIIB: 276.34 (+10.53), JNJ: 97.63 (+0.04), AMGN: 150.09 (-0.36), IBB: 304.46 (-1.50)
Biotech Stocks Slump Again on Valeant's 'Smoking Gun'
at The Street - Wed Oct 21, 3:02PM CDT
Biotech stocks were in the crossfire again on Wednesday as investors fled. But this time Hillary Clinton wasn't to blame.
KO: 42.19 (-0.10), VRX: 118.61 (-28.13), F: 15.41 (+0.03), KMB: 118.09 (+0.87), PFE: 33.46 (-0.54), IBB: 304.46 (-1.50), FCAU: 15.20 (-0.74), LLY: 77.01 (-0.78), TM: 123.70 (+1.49), BMY: 62.51 (-1.38), BA: 141.19 (+2.31), GM: 35.42 (+1.94), ABBV: 53.83 (-1.00), HMC: 32.70 (+0.70), RACE: 55.00 (-5.00)
Stocks Fall; Valeant Defends Accounting Practices
at The Street - Wed Oct 21, 2:02PM CDT
Stocks relinquish gains made earlier Wednesday as a selloff in Valeant Pharmaceuticals pressures the rest of the biotech sector.
TSLA: 210.09 (-2.94), BIIB: 276.34 (+10.53), F: 15.41 (+0.03), VRX: 118.61 (-28.13), KMB: 118.09 (+0.87), IBB: 304.46 (-1.50), TM: 123.70 (+1.49), SBUX: 60.53 (-0.35), YHOO: 31.12 (-1.71), CMG: 665.67 (-39.96), ABBV: 53.83 (-1.00), GOOGL: 671.80 (-8.20), HMC: 32.70 (+0.70), AAPL: 113.76 (-0.01), KO: 42.19 (-0.10), AMZN: 555.77 (-5.11), MU: 16.43 (-0.66), PFE: 33.46 (-0.54), LLY: 77.01 (-0.78), FCAU: 15.20 (-0.74), BMY: 62.51 (-1.38), BA: 141.19 (+2.31), WDC: 71.44 (-3.42), LRCX: 70.79 (+0.76), MCD: 102.54 (-1.30), GM: 35.42 (+1.94), KLAC: 63.98 (+10.12), RACE: 55.00 (-5.00), SNDK: 76.78 (+1.59)
Carl Icahn Forming Super PAC to Push Corporate Tax Reform
at The Street - Wed Oct 21, 1:26PM CDT
The CNBC 'Fast Money' traders get the latest on the Valeant Pharma stock plunge, then hear from Carl Icahn on why he's forming a super PAC focused on corporate taxes.
VRX: 118.61 (-28.13), SPY: 201.85 (-1.24), GM: 35.42 (+1.94), IBB: 304.46 (-1.50), BA: 141.19 (+2.31), AAPL: 113.76 (-0.01)
Stocks Turn Lower as Valeant Dents Biotech Sector
at The Street - Wed Oct 21, 9:41AM CDT
Stocks turn lower by mid-morning Wednesday as plummeting Valeant Pharmaceuticals shares pull the biotech sector to the downside.
BIIB: 276.34 (+10.53), TSLA: 210.09 (-2.94), VRX: 118.61 (-28.13), KMB: 118.09 (+0.87), IBB: 304.46 (-1.50), SBUX: 60.53 (-0.35), YHOO: 31.12 (-1.71), CMG: 665.67 (-39.96), ABBV: 53.83 (-1.00), GOOGL: 671.80 (-8.20), AAPL: 113.76 (-0.01), KO: 42.19 (-0.10), AMZN: 555.77 (-5.11), MU: 16.43 (-0.66), PFE: 33.46 (-0.54), FCAU: 15.20 (-0.74), BA: 141.19 (+2.31), WDC: 71.44 (-3.42), CELG: 115.92 (-0.32), GILD: 101.73 (+0.07), LRCX: 70.79 (+0.76), GM: 35.42 (+1.94), MCD: 102.54 (-1.30), KLAC: 63.98 (+10.12), RACE: 55.00 (-5.00), SNDK: 76.78 (+1.59)
Stocks Slide as Health Care Selloff Dings Nasdaq
at The Street - Tue Oct 20, 1:37PM CDT
Stocks are lower by mid-afternoon Tuesday, pulled down by weakness in the tech and health care sectors.
BIIB: 276.34 (+10.53), TSLA: 210.09 (-2.94), GE: 28.85 (+0.07), VRX: 118.61 (-28.13), HOG: 47.03 (-1.22), UTX: 97.97 (+2.35), TFM: 26.64 (-0.96), IBB: 304.46 (-1.50), T: 33.60 (-0.15), SONC: 27.87 (-0.82), IBM: 140.92 (+0.28), S: 4.34 (-0.02), XLK: 41.70 (-0.32), SYF: 32.46 (+0.12), GOOGL: 671.80 (-8.20), TMUS: 40.22 (-0.48), YUM: 73.56 (+0.53), TRV: 110.70 (+1.75), AMSG: 71.56 (-3.32), AMZN: 555.77 (-5.11), PFE: 33.46 (-0.54), WDC: 71.44 (-3.42), VOD: 31.93 (-0.27), UAL: 54.55 (-1.20), NFLX: 97.96 (-1.03), LVLT: 47.36 (-0.73), GILD: 101.73 (+0.07), WTW: 15.40 (-2.85), TMH: 61.77 (-0.82), VZ: 44.86 (-0.38), SNDK: 76.78 (+1.59), BABA: 69.48 (-2.31)
Breakthrough Biotech ETF on Cancer Treatment
Zacks Equity Research - Zacks Investment Research - Mon Oct 19, 12:54PM CDT
Want exposure to an innovative biotech field? The first cancer immunotherapy ETF (CNCR) is now within your reach.
BBP: 28.82 (+0.02), BBC: 26.84 (-0.09), SBIO: 28.07 (-0.21), CNCR: 26.22 (-0.24), IBB: 304.46 (-1.50), XLV: 68.29 (-0.62)
Bull of the Day: Repligen (RGEN)
Kevin Cook - Zacks Investment Research - Mon Oct 19, 8:01AM CDT
Bull of the Day: Repligen (RGEN)
RGEN: 30.65 (-0.06), GE: 28.85 (+0.07), TMO: 127.11 (-1.51), IBB: 304.46 (-1.50)
The Best Way to Invest $1,000 Right Now
Sean Williams, Selena Maranjian, and Dan Caplinger, The Motley Fool - Motley Fool - Sun Oct 18, 10:11AM CDT
Image source: Federal Reserve Bank of New York. They say you need money to make money, but everyone needs to start somewhere. So why not now? With this in mind, we posed the following question to three of our investment planning contributors:...
IBB: 304.46 (-1.50)
3 Biotechs Stocks That We Think The Market Has All Wrong
Brian Feroldi, Todd Campbell, and George Budwell, The Motley Fool - Motley Fool - Sat Oct 17, 12:41PM CDT
Image Source: TBIT via pixabay It's been a rough couple of months for biotech investors, as the entire sector has been sold off hard since the summer. The iShares Nasdaq Biotechnology ETF , which holds a huge collection of biotech stocks, is down...
INSY: 23.66 (-0.70), GWPH: 85.62 (-3.60), IBB: 304.46 (-1.50), DEPO: 16.12 (-0.95)
Is the Recent Stock Rally About to End?
at The Street - Fri Oct 16, 1:58PM CDT
A majority of the CNBC 'Fast Money' traders aren't buying into the recent stock rally that has sent the S&P 500 higher by 5.5% this month.
SPY: 201.85 (-1.24), GILD: 101.73 (+0.07), IBB: 304.46 (-1.50), MSFT: 47.20 (-0.57), TWTR: 29.30 (-1.61)
iShares Nasdaq Biotechnology Index Set to Possibly Pullback After Yesterday's Rally of 4.37%
Comtex SmarTrend(R) - Thu Oct 15, 3:46PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $297.38 to a high of $314.85. Yesterday, the shares gained 4.4%, which took the trading range above the 3-day high of $312.48 on volume of 3.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 304.46 (-1.50)
SmarTrend Watching for Potential Pullback in Shares of iShares Nasdaq Biotechnology Index After 4.37% Gain
Comtex SmarTrend(R) - Thu Oct 15, 3:46PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $297.38 to a high of $314.85. Yesterday, the shares gained 4.4%, which took the trading range above the 3-day high of $312.48 on volume of 3.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 304.46 (-1.50)
These 3 Biotechs Have Been Falling Like a Knife in 2015 -- Is 1 Now a Buy?
George Budwell, The Motley Fool - Motley Fool - Thu Oct 15, 8:37AM CDT
Source: Pixabay. After a long bull run, biotech has finally stubbed its proverbial toe in 2015, with the iShares Nasdaq Biotechnology Index giving back nearly all of its gains from earlier in the year: Worse still, numerous biotechs...
OVAS: 14.41 (+0.38), IBB: 304.46 (-1.50), KERX: 4.62 (+0.02)
Downtrend Call Working As iShares Nasdaq Biotechnology Index Stock Falls 6.9% (IBB)
Comtex SmarTrend(R) - Wed Oct 14, 10:12AM CDT
SmarTrend identified a Downtrend for iShares Nasdaq Biotechnology Index (AMEX:IBB) on September 24th, 2015 at $326.22. In approximately 3 weeks, iShares Nasdaq Biotechnology Index has returned 6.87% as of today's recent price of $303.81.
IBB: 304.46 (-1.50)
Trader's Notebook: Post-Debate Biotech and Post-Earnings Bank of America
at The Street - Wed Oct 14, 8:00AM CDT
How to play the IBB and earnings from Intel, BAC, Delta and Netflix.
NFLX: 97.96 (-1.03), DAL: 49.44 (-0.71), IBB: 304.46 (-1.50), BAC: 15.90 (-0.30), INTC: 33.37 (-0.07)
Five Biotech Stocks, Including Biogen (BIIB), With Bullish Charts, Pushing the Sector Higher
at The Street - Tue Oct 13, 3:00PM CDT
The common thread in these five names is the bullish divergence between the lower lows in price and the higher low in the momentum study.
BIIB: 276.34 (+10.53), GILD: 101.73 (+0.07), AMGN: 150.09 (-0.36), IBB: 304.46 (-1.50), REGN: 518.53 (+3.86), CELG: 115.92 (-0.32)
5 Biotech Stocks With Bullish Charts That Will Push the Sector Higher
at The Street - Tue Oct 13, 2:30PM CDT
The common thread in these 5 names is the bullish divergence between the lower lows in price and the higher low in the momentum study.
BIIB: 276.34 (+10.53), GILD: 101.73 (+0.07), AMGN: 150.09 (-0.36), IBB: 304.46 (-1.50), REGN: 518.53 (+3.86), CELG: 115.92 (-0.32)
Trader's Notebook: Johnson & Johnson May Be Worth a Look
at The Street - Tue Oct 13, 8:00AM CDT
And watch out for surprises in the biotech sector.
BIIB: 276.34 (+10.53), JNJ: 97.63 (+0.04), AMGN: 150.09 (-0.36), IBB: 304.46 (-1.50)
